ARWR Stock Analysis: Buy, Sell, or Hold?
ARWR - Arrowhead Research Corporation
$84.65
-2.67 (-3.06%)
▼
5d:
-1.11%
30d:
+5.23%
90d:
+15.2%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Smart Money Distribution
None View Scanner →
Strength: 6.6/10
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ARWR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ARWR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $84.65, which is considered slightly high relative to its 30-day fair value range of $75.46 to $86.35.
Technical Outlook: Technically, ARWR is in a strong uptrend. Immediate support is located at $71.00, while resistance sits at $95.49. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: ARWR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $106.09 (+25.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARWR is in a strong uptrend. Immediate support is located at $71.00, while resistance sits at $95.49. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: ARWR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $106.09 (+25.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$75.46 -
$86.35
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.7%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 25.3% below Wall St target ($106.09)
Trading Range Analysis
30-Day Trading Range
$75.46 -
$86.35
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$71.00
Resistance Level
$95.49
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-18.55
Wall Street Target
$106.09
(+25.3%)
Revenue Growth (YoY)
-86.4%
Earnings Growth (YoY)
9.8%
Profit Margin
-48.4%
Share & Embed Analysis
Last updated: August 03, 2026 1:53 AM ET
Data refreshes hourly during market hours. Next update: 2:53 AM
Data refreshes hourly during market hours. Next update: 2:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
James C Hamilton
SELL
10000 shares
2026-04-23
Daniel Joseph Apel
SELL
13095 shares
2026-04-22
James C Hamilton
SELL
10000 shares
2026-03-05
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
